```json
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "Peripheral Anergy Induction Maintains Tolerance in AQP4-Specific B Cells",
"mechanism": "AQP4-specific B cells that escape central tolerance become functionally anergic upon encountering antigen in secondary lymphoid organs, maintaining unresponsiveness through reduced BCR signaling and altered metabolic states.",
"target_gene": "BTK",
"confidence_score": 0.75,
"novelty_score": 0.5,
"feasibility_score": 0.8,
"impact_score": 0.8,
"composite_score": 0.73,
"testable_prediction": "Measure calcium signaling responses and BCR proximal kinase phosphorylation in AQP4-tetramer+ B cells from healthy controls versus NMO patients; anergic cells will show blunted signaling.",
"skeptic_concern": "Anergic cells are reversible and may reactivate if cytokine milieu shifts, raising questions about durability of tolerance maintenance."
},
{
"rank": 2,
"title": "Regulatory B Cell (B10) Mediated Suppression of AQP4-Reactive Clones",
"mechanism": "IL-10-producing regulatory B cells actively suppress AQP4-specific B cell activation through cytokine-mediated inhibition in germinal centers, preventing autoantibody class-switching.",
"target_gene": "IL10",
"confidence_score": 0.65,
"novelty_score": 0.6,
"feasibility_score": 0.75,
"impact_score": 0.7,
"composite_score": 0.67,
"testable_prediction": "Deplete B10 cells in a humanized mouse model using CD19-directed antibodies and measure anti-AQP4 antibody titers; tolerance should break upon depletion.",
"skeptic_concern": "Breg-mediated suppression is non-antigen-specific and may not explain durable tolerance maintenance to a single autoantigen."
},
{
"rank": 3,
"title": "Central Tolerance via CNS Antigen Presentation in Bone Marrow Niches",
"mechanism": "Microglial precursor cells or ectopic CNS-resident progenitor cells in bone marrow present AQP4 to developing B cells, enabling RAG-mediated receptor editing of autoreactive BCRs.",
"target_gene": "RAG1/2",
"confidence_score": 0.5,
"novelty_score": 0.85,
"feasibility_score": 0.35,
"impact_score": 0.75,
"composite_score": 0.60,
"testable_prediction": "Perform single-cell RNA sequencing of bone marrow stromal cells to identify AQP4-expressing populations; validate with AQP4-immunostaining of bone marrow sections.",
"skeptic_concern": "AQP4 expression in bone marrow is not established; the anatomical paradox of CNS antigens accessing bone marrow for central tolerance remains unresolved."
}
],
"consensus_points": [
"B cells are actively involved in maintaining tolerance to AQP4, not passively ignoring the autoantigen",
"Peripheral tolerance mechanisms are plausible and testable using contemporary B cell assays",
"Failure of B cell tolerance mechanisms likely underlies NMO pathogenesis"
],
"dissent_points": [
"Mechanistic site of tolerance (central vs. peripheral) remains contested; the anatomical paradox raised by the skeptic challenges central tolerance hypotheses without resolution"
],
"debate_summary": "The theorist proposed central tolerance via bone marrow receptor editing, but the skeptic's anatomical paradox critique—AQP4 is CNS-restricted with no established bone marrow presence—substantially undermines this hypothesis. The expert correctly noted domain-specific context. The ranked synthesis prioritizes peripheral anergy (highest composite score, addresses anatomical paradox, strong feasibility) over Breg-mediated suppression and speculative central tolerance with novel-but-low-feasibility bone marrow antigen presentation."
}
```